Skip to main content
. 2012 Sep 6;13(5):62–73. doi: 10.1120/jacmp.v13i5.3806

Table 1.

The dose constrains and the relative priority used during optimization for multiple partial VMAT planning.

Structures Criteria Dose Limit (% of Rx dose)/(Gy) Priority (Level 1–3) Priority (Level 4–5)
PTV
V95
>95% of Rx 120 400
Maximum dose 0%
>110%
250 450
Heart Mean dose 9Gy 120 120
V5
<70%
V10
<30%
V25
<5%
V30
<2.5%
Left Lung Mean dose 10Gy 80–250 80–250
V5
<45%
V10
<30%
V20
<15%
Right Lung Mean dose 4Gy
V5
<20% 120–250 120–250
V10
<0.5%
TLV Mean dose 6.5Gy
V5
<25% none none
V20
<10%
Right Breast Mean dose 2.5Gy 120–250 120–250
Maximum dose 10Gy
V5
<5%
V10
<0.5%

Rx: prescription; TLV: total lung volume